Effect of Abelmoschus esculentus (okra) on metabolic syndrome: A review.
Danial EsmaeilzadehBiBi Marjan RazaviMahboobeh Ghasemzadeh RahbardarPublished in: Phytotherapy research : PTR (2020)
Metabolic syndrome is a disorder characterized by dyslipidemia, insulin resistance, abdominal fat, high blood pressure, hypertriglyceridemia, and diminished high density lipoprotein cholesterol. Okra (Abelmoschus esculentus L.), routinely called lady's finger, has belonged to the Malvaceae family. Okra is considered as a valuable crop due to the multiple functions of its leaves, buds, flowers, pods, stems, and seeds in traditional and modern medicines. Several bioactive components are presented in different parts of okra including polyphenolic compounds especially oligomeric catechins and flavonol derivatives such as quercetin. The antioxidant, anti-inflammatory, anticancer, immunomodulatory, gastroprotective, neuroprotective, lipid lowering, and antidiabetic effects of okra have been established. Although different in vivo and in vitro studies revealed that okra has an ability to overcome metabolic syndrome symptoms, the lack of clinical studies is notable. So, further clinical trials should be accomplished to confirm the role of okra in metabolic syndrome. The aims of this review are to gather different studies regarding the potential efficacy of okra in metabolic syndrome.
Keyphrases
- metabolic syndrome
- insulin resistance
- uric acid
- blood pressure
- anti inflammatory
- clinical trial
- cardiovascular risk factors
- adipose tissue
- high fat diet
- randomized controlled trial
- cardiovascular disease
- type diabetes
- oxidative stress
- skeletal muscle
- risk assessment
- blood glucose
- case control
- human health
- hypertensive patients
- depressive symptoms
- glycemic control